[1]许莉军,姜艳,夏维波.低磷酸酶血症的研究进展[J].国际内分泌代谢杂志,2015,(03):211-214.[doi:10.3760/cma.j.issn.1673-4157.2015.03.020]
　Xu Lijun,Jiang Yan,Xia Weibo..Research progress of hypophosphatasia[J].International Journal of Endocrinology and Metabolism,2015,(03):211-214.[doi:10.3760/cma.j.issn.1673-4157.2015.03.020]

点击复制

低磷酸酶血症的研究进展()

分享到：

参考文献/References:

[1]　Mornet E.Hypophosphatasia [J].Orphanet J Rare Dis，2007，2：40. 　
[2]　RATHBUN JC.Hypophosphatasia：a new developmental anomaly [J].Am J Dis Child，1948，75（6）：822-831. 　
[3]　Mornet E，Yvard A，Taillandier A，et al.A molecular-based estimation of the prevalence of hypophosphatasia in the European population [J].Ann Hum Genet，2011，75（3）：439-445. 　
[4]　Mornet E.Hypophosphatasia[J].Best Pract Res Clin Rheumato，2008，22（1）：113-127. 　
[5]　Sultana S，Al-Shawafi HA，Makita S，et al.An asparagine at position 417 of tissue-nonspecific alkaline phosphatase is essential for its structure and function as revealed by analysis of the N417S mutation associated with severe hypophosphatasia [J].Mol Genet Metab，2013，109（3）：282-288. 　
[6]　Hessle L，Johnson KA，Anderson HC，et al.Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization [J].Proc Natl Acad Sci U S A，2002，99（14）：9445-9449. 　
[7]　Mornet E.Genetics of hypophosphatasia[J].Clinic Rev Bone Miner Metab，2013，11：71-77. 　
[8]　Whyte MP，Essmyer K，Geimer M，et al.Homozygosity for TNSALP mutation 1348c＞T（Arg433Cys） causes infantile hypophosphatasia manifesting transient disease correction and variably lethal out-come in a kindred of black ancestry[J].J Pediatr，2006，148（6）：753-758. 　
[9]　Zurutuza L，Muller F，Gibrat JF，et al.Correlations of genotype and phenotype in hypophosphatasia [J].Hum Mol Genet，1999，8（6）： 1039-1046.
[10]　Satou Y，Al-Shawafi HA，Sultana S，et al.Disulfide bonds are critical for tissue-nonspecific alkaline phosphatase function revealed by analysis of mutant proteins bearing a C（201）-Y or C（489）-S substitution associated with severe hypophosphatasia [J].Biochim Biophys Acta， 2012，1822（4）：581-588.
[11]　Mornet E，Stura E，Lia-Baldini AS，et al.Structural evidence for a functional role of human tissue nonspecific alkaline phos-phatase in bone mineralization [J].J Biol Chem，2001，276（33）：31171-31178.
[12]　Fauvert D，Brun-Heath I，Lia-Baldini AS，et al.Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles [J].BMC Med Genet，2009，10：51.
[13]　Lia-Baldini AS，Muller F，Taillandier A，et al.A molecular approach to dominance in hypophosphatasia[J].Hum Genet，2001， 109（1）： 99-108.
[14]　Lia-Baldini AS，Brun-Heath I，Carrion C，et al.A new mechanism of dominance in hypophosphatasia：the mutated protein can disturb the cell localization of the wild-type protein [J].Hum Genet，2008，123（4）：429-432.
[15]　Taketani T，Onigata K，Kobayashi H，et al.Clinical and genetic aspects of hypophosphatasia in Japanese patients[J].Arch Dis Child，2014，99（3）：211-215.
[16]　Berkseth KE，Tebben PJ，Drake MT，et al.Clinical spectrum of hypophosphatasia diagnosed in adults[J].Bone，2013，54（1）：21-27.
[17]　Guanabe?觡s N，Mumm S，M?觟ller I，et al.Calcific periarthritis as the only clinical manifestation of hypophosphatasia in middle-aged sisters [J].J Bone Miner Res，2014，29（4）：929-934.
[18]　Girschick HJ，Schneider P，Haubitz I，et al.Effective NSAID treatment indicates that hyperprostaglandinism is affecting the clinical severity of childhood hypophosphatasia[J].Orphanet J Rare Dis，2006，1：24.
[19]　Doshi KB，Hamrahian AH，Licata AA.Teriparatide treatment in adult hypophosphatasia in a patient exposed to bisphosphonate：a case report[J].Clin Cases Miner Bone Metab，2009，6（3）：266-269.
[20]　Schalin-J?覿ntti C，Mornet E，Lamminen A，et al.Parathyroid hormone treatment improves pain and fracture healing in adult hypophosphatasia[J].J Clin Endocrinol Metab，2010，95（12）：5174-5179.
[21]　Taketani T，Kanai R，Abe M，et al.Therapy-related Ph+ leukemia after both bone marrow and mesenchymal stem cell transplantation for hypophosphatasia [J].Pediatr Int，2013，55（3）： e52-e55.
[22]　Whyte MP，Kurtzberg J，McAlister WH，et al.Marrow cell trans-plantation for infantile hypophosphatasia[J].J Bone Miner Res，2003，18（4）： 624-636.
[23]　Yadav MC，de Oliveira RC，Foster BL，et al.Enzyme replacement prevents enamel defects in hypophosphatasia mice[J].J Bone Miner Res，2012，27（8）：1722-1734.
[24]　Whyte MP，Greenberg CR，Salman NJ，et al.Enzyme-replacement therapy in life-threatening hypophosphatasia [J].N Engl J Med，2012， 366（10）：904-913.
[25]　Kosnik-Infinger L，Gendron C，Gordon CB，et al.Enzyme replacement therapy for congenital hypophosphatasia allows for surgical treatment of related complex craniosynostosis：a case series[J].Neurosurg Focus，2015，38（5）：E10.
[26]　Oikawa H，Tomatsu S，Haupt B，et al.Enzyme replacement therapy on hypophosphatasia mouse model[J].J Inherit Metab Dis，2014， 37（2）：309-317.
[27]　Mohn A，De Leonibus C，de Giorgis T，et al.Hypophosphatasia in a child with widened anterior fontanelle：lessons learned from late diagnosis and incorrect treatment[J].Acta Paediatr，2011， 100（7）：e43-e46.
[28]　Sutton RA，Mumm S，Coburn SP，et al."Atypical femoral frac-tures" during bisphosphonate exposure in adult hypophosphatasia[J].J Bone Miner Res，2012，27（5）：987-994.
[29]　Faruqi T，Dhawan N，Bahl J，et al.Molecular， phenotypic aspects and therapeutic horizons of rare genetic bone disorders [J]. Biomed Res Int，2014，2014：670842.